awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37709519-DA2C8433-3668-4F5F-A7B3-D94E2E60E0E1
Q37709519-DA2C8433-3668-4F5F-A7B3-D94E2E60E0E1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37709519-DA2C8433-3668-4F5F-A7B3-D94E2E60E0E1
Preliminary experience with dosimetry, response and patient reported outcome after 177Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer
P2860
Q37709519-DA2C8433-3668-4F5F-A7B3-D94E2E60E0E1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37709519-DA2C8433-3668-4F5F-A7B3-D94E2E60E0E1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e198cb7333e5086c7548ab97fbd24ccba85dc523
P2860
[177Lu-PSMA-617 therapy, dosimetry and follow-up in patients with metastatic castration-resistant prostate cancer].